FDA OKs Pfizer To Test COVID-19 Vaccine On Kids As Young As 12

The video discusses parental concerns about COVID-19's impact on children, highlighting the risks and statistics of infection. It covers Pfizer's vaccine trials for children aged 12 and up, addressing questions about safety and effectiveness. The American Academy of Pediatrics supports including children in trials, emphasizing the need for diversity. The video also touches on the challenges of vaccine development and hopes for availability by fall 2021.

What age group is Pfizer initially testing its experimental COVID vaccine on?

• Children as young as 5

• Children as young as 12

• Children as young as 16

• Children as young as 18

Why is it important to test vaccines specifically in children before FDA approval?

• Children's immune systems are still developing

• Children are less likely to get sick

• Children have the same immune response as adults

• Children do not need vaccines

What is a key concern for health experts regarding vaccine trials for adolescents?

• The trials should exclude certain groups

• The trials should be diverse

• The trials should be secretive

• The trials should be quick

Which groups of children are at a higher risk for COVID-19 complications according to the data?

• Asian and White children

• Black and Latino children

• Native American and Pacific Islander children

• All children equally

By when does the American Academy of Pediatrics hope a COVID-19 vaccine will be available for children?

• Winter 2021

• Spring 2021

• Summer 2021

• Fall 2021